Evidence map›Paper›PMID 28396541›Full record

ArticleAntimicrobial agents and chemotherapy2017

Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.

Julia V Bugrysheva, David Sue, Jay E Gee, Mindy G Elrod, Alex R Hoffmaster, Linnell B Randall, Sunisa Chirakul, Apichai Tuanyok, Herbert P Schweizer, Linda M Weigel

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Genetic Engineering of Lysogenic-Lytic Switch Genes ImprovesInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Antimicrobial agents and chemotherapy · 2025
    Article
  7. Genomic insights into ceftazidime resistance inAntimicrobial agents and chemotherapy · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Burkholderia pseudomallei and melioidosis.Nature reviews. Microbiology · 2024
    Review
  12. Article
  13. Article
  14. Antibiotic susceptibility of clinicalAntimicrobial agents and chemotherapy · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Julia V BugryshevaCenters for Disease Control and Prevention, Atlanta, Georgia, USA jbugrysheva@cdc.gov.
David SueCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Jay E GeeCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Mindy G ElrodCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Alex R HoffmasterCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Linnell B RandallDepartment of Molecular Genetics and Microbiology, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Sunisa ChirakulDepartment of Molecular Genetics and Microbiology, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Apichai TuanyokDepartment of Molecular Genetics and Microbiology, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Herbert P SchweizerDepartment of Molecular Genetics and Microbiology, Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.
Linda M WeigelCenters for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USUniversity of Florida · US

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-LactamasesBurkholderia pseudomalleiCeftazidimeDrug Resistance, Multiple, BacterialGenome, BacterialHumansImipenemMelioidosisMembrane Transport ProteinsMicrobial Sensitivity TestsSequence Analysis, DNATetrahydrofolate DehydrogenaseTrimethoprimAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agentsbeta-LactamasesCeftazidimeImipenemMembrane Transport ProteinsTetrahydrofolate DehydrogenaseTrimethoprimantimicrobial resistanceBurkholderia pseudomalleigenome sequencepenA

Identifiers

PMID28396541
PMCPMC5444168
OpenAlexW2606202207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.